Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beuzeboc

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
BJU International|March 17, 2010
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre studyJean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, et al.
Clinical Genitourinary Cancer|October 10, 2009
Drug management of prostate cancer: prevalence and consequences of renal insufficiencyVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Lung|October 23, 2008
Lung cancer and renal insufficiency: prevalence and anticancer drug issuesVincent Launay-Vacher, Reza Etessami, Nicolas Janus, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After MastectomyNoemie Grellier Adedjouma, Marion Chevrier, Alain Fourquet, et al.
European Cytokine Network|April 17, 2002
Circulating macrophage colony stimulating factor as a marker of tumour progressionRaymond S McDermott, Laurent Deneux, Véronique Mosseri, et al.
Breast Cancer Research and Treatment|August 16, 2008
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issuesVincent Launay-Vacher, Joseph Gligorov, Christophe Le Tourneau, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapyAnne Vincent-Salomon, Alexandra Rousseau, Michel Jouve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancerKarim Fizazi, Philippe Beuzeboc, Jean Lumbroso, et al.
Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.
Cancer|April 29, 2009
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinomaChristian Wülfing, Jean-Pascal H Machiels, Dirk J Richel, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
BJU International|March 17, 2010
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre studyJean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, et al.
Clinical Genitourinary Cancer|October 10, 2009
Drug management of prostate cancer: prevalence and consequences of renal insufficiencyVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Lung|October 23, 2008
Lung cancer and renal insufficiency: prevalence and anticancer drug issuesVincent Launay-Vacher, Reza Etessami, Nicolas Janus, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After MastectomyNoemie Grellier Adedjouma, Marion Chevrier, Alain Fourquet, et al.
European Cytokine Network|April 17, 2002
Circulating macrophage colony stimulating factor as a marker of tumour progressionRaymond S McDermott, Laurent Deneux, Véronique Mosseri, et al.
Breast Cancer Research and Treatment|August 16, 2008
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issuesVincent Launay-Vacher, Joseph Gligorov, Christophe Le Tourneau, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapyAnne Vincent-Salomon, Alexandra Rousseau, Michel Jouve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancerKarim Fizazi, Philippe Beuzeboc, Jean Lumbroso, et al.
Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.
Cancer|April 29, 2009
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinomaChristian Wülfing, Jean-Pascal H Machiels, Dirk J Richel, et al.
Pageof 13